{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:27Z","timestamp":1755216747456,"version":"3.43.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>X-linked inhibitor of apoptosis protein (XIAP) deficiency is an inborn error of immunity (IEI). Allogeneic hematopoietic cell transplantation (HCT) is currently the only curative therapy available for XIAP deficiency. Granulomatous and lymphocytic interstitial lung disease (GLILD) is a common immune-related lung complication of IEIs. We present a 6-year-old boy with XIAP deficiency and GLILD. Computed tomography showed lung nodes but no symptoms. Before HCT, GLILD was not managed with immunosuppressive therapy, because he was asymptomatic. The HCT procedure was subsequently performed. The post-HCT course was uneventful; follow-up computed tomography on day 46 showed nodules had disappeared. HCT could potentially ameliorate GLILD like other inflammatory processes associated with the underlying IEIs.<\/jats:p>","DOI":"10.1097\/mph.0000000000002819","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T16:00:23Z","timestamp":1706284823000},"page":"e191-e194","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Allogeneic Hematopoietic Cell Transplantation Ameliorated Asymptomatic Granulomatous and Lymphocytic Interstitial Lung Disease in a Patient With XIAP Deficiency"],"prefix":"10.1097","volume":"46","author":[{"given":"Mai","family":"Oshima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhachi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Taga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Maruo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood-2012-06-432500","article-title":"Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes","volume":"121","author":"Marsh","year":"2013","journal-title":"Blood"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/pbc.25756","article-title":"Successful allogeneic hematopoietic stem cell transplantation in XIAP deficiency using reduced-intensity conditioning","volume":"63","author":"Chellapandian","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.bmt.1705016","article-title":"Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature","volume":"36","author":"Lankester","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"660520","DOI":"10.3389\/fped.2021.660520","article-title":"Evolution of our understanding of XIAP deficiency","volume":"9","author":"Mudde","year":"2021","journal-title":"Front Pediatr"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s10875-021-01032-4","article-title":"Epstein-Barr virus-negative granulomatous disease due to SAP deficiency","volume":"41","author":"Karasawa","year":"2021","journal-title":"J Clin Immunol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"627423","DOI":"10.3389\/fimmu.2021.627423","article-title":"Granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID): a multicenter retrospective study of patients from Italian PID referral centers","volume":"12","author":"Cinetto","year":"2021","journal-title":"Front Immunol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"606099","DOI":"10.3389\/fimmu.2021.606099","article-title":"Treatment strategies for GLILD in common variable immunodeficiency: a systematic review","volume":"12","author":"Lamers","year":"2021","journal-title":"Front Immunol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10875-021-01188-z","article-title":"Identification of germline non-coding deletions in XIAP gene causing XIAP deficiency reveals a key promoter sequence","volume":"42","author":"Sbihi","year":"2022","journal-title":"J Clin Immunol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10875-016-0320-3","article-title":"X-linked inhibitor of apoptosis complicated by granulomatous lymphocytic interstitial lung disease (GLILD) and granulomatous hepatitis","volume":"36","author":"Steele","year":"2016","journal-title":"J Clin Immunol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3389\/fimmu.2018.01837","article-title":"The lung in primary immunodeficiencies: new concepts in infection and inflammation","volume":"9","author":"Baumann","year":"2018","journal-title":"Front Immunol"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"122728","DOI":"10.1172\/jci.insight.122728","article-title":"BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency","volume":"4","author":"Maglione","year":"2019","journal-title":"JCI Insight"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41467-018-02862-4","article-title":"IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells","volume":"9","author":"Hsieh","year":"2018","journal-title":"Nat Commun"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10875-016-0348-4","article-title":"Hematopoietic stem cell transplantation for XIAP deficiency in Japan","volume":"37","author":"Ono","year":"2017","journal-title":"J Clin Immunol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:04:45Z","timestamp":1754337885000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002819","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2024,1,22]]},"assertion":[{"value":"2023-07-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}